Inspire Pharmaceuticals 10K 2006 Annual report | ISPH Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: aboutProlacriaand, abuse, Academy, adherence, Alacrity, Allegan, Allergology, anAzaSite, anAzaSiteapproval, anAzaSiteFDA, andAllegra, andAzopt®andTravatan®by, andCiloxan, andClaritin, andElestatwill, andOcuflox, andPataday, andPatanol, andProlacria, andQuixin, andTobryaDex, annum, approveAzaSite, approveProlacria, aspect, asserting, Asthma, Austria, automatically, AzaSite, AzaSitelaunch, azithromycin, bacterial, Bausch, Belize, bilastine, BioPharma, Blvd, borrow, borrowed, borrowing, BothPataday, broadly, bulbar, CAC, Canadian, cardiac, cedar, CFTR, Chemedica, ciclesonide, cigarette, commercializeAzaSite, commercializeProlacriaworldwide, congestion, conjunctival, constant, construed, Contemporaneously, Costa, coveringElestatwill, crossover, currentElestat, customary, cytoskeletal, depositary, depository, developingProlacria, dialogue, discharge, disciplinary, discount, disgorgement, distributor, dollar, doxycycline, eitherAzaSite, El, eleven, EMEA, enzyme, erythromycin, eventAzaSite, eventProlacria, expressed, Farma, forAzaSite, forElestatand, forElestatandRestasisbeginning, forfeited, forfeiture, formulary, forProlacria, forProlacriaand, forProlacriafor, fraud, fromProlacria, gentamycin, graft, grown, Guatemala, headcount, history, honest, hutson, hyaluronate, idiopathic, ifazasite, ifProlacria, Immunology, impede, imposition, inAzaSite, includeVigamox, includeXyzal, includeZyrtec, inclusion, incremental, injunctive, InSite, irrevocable, Justice, launchedPataday, lending, levocetirizine, loan, Lomb, lowest, Lynch, lysine, margin, marketingProlacria, Merrill, misconduct, mitigating, ml, motion, mountain, multiplied, nameZithromax, nancy, Nicaragua, noncompliance, nonexclusive, nose, notification, ofAzaSite, ofAzaSiteand, ofAzaSitefor, ofAzaSiteTM, ofBronchitolTM, ofElestatand, ofElestatandRestasisexceeded, ofElestatfor, ofElestathave, ofElestatin, ofProlacria, ofProlacriaand, ofRestasisfor, ofRestasisoutside, ofRestasisto, ofZaditor, ofZaditorcurrently, onProlacriadue, orProlacria, ourProlacriaprogram, owe, palpebral, Panama, PDUFA, penalty, perfume, pharmacovigilance, pleading, PlusTM, pollen, Portugal, prepay, productAzaSite, Prolacria, Prolacriaand, prosecutorial, PTS, quantification, quantify, Quantifying, qui, reborrowed, regardingAzaSite, repaid, repayment, reputation, respectfully, rhinorrhea, Rica, runny, Salvador, scrutiny, sellProlacria, sentence, shareholder, shift, Silicon, SinceProlacria, smoke, sneezing, sought, Spagnardi, Spain, staining, step, stockpile, substantively, supplyAzaSite, Sweden, tablet, tam, temporarily, thatProlacria, theAzaSite, theDuraSite, threshold, toAzaSite, tradename, TRB, trend, UCB, unblind, unblinding, uncured, unpaid, unrecognized, urticaria, usage, User, utilizingDuraSite, Valley, version, Vienna, violate, violation, VISMED, Vistakon, windfall, Winter, withDuraSite, withProlacria, writing, wrongdoing

Removed: accomplish, accumulation, acknowledged, acuity, administer, aggregation, aid, alternate, Androgen, blood, Brewery, cancer, Cangrelor, cardiopulmonary, Chapel, Chiron, Ciliary, designing, detachment, Deutsche, discover, drainage, duct, Dyskinesia, employed, enhanced, Equivalence, ethically, exclusively, extremely, feel, fill, foregoing, fulfilled, functional, Gregory, Hill, honestly, Imperial, inhibit, inhibition, initially, inserted, intravitreal, irreversibly, Jaffray, jurisdiction, Kirin, lawfully, leadership, macular, morbidity, Mossinghoff, mucin, Orange, originally, partnership, Petula, Piper, planning, platform, Plavix, progressed, publication, purpose, recruit, reflecting, replacement, retina, returned, rubber, separate, shortage, show, skill, Squibb, surgery, synthesizing, tolerated, tool, transaction, UNC, underwriting, University, uridine, visual

Inspire Pharmaceuticals (ISPH) Inactive 10-K2006 FY Annual report

Content analysis